BSX Share Price

Open 20.72 Change Price %
High 20.86 1 Day 0.10 0.48
Low 20.61 1 Week 0.35 1.71
Close 20.81 1 Month -1.23 -5.58
Volume 7724342 1 Year 2.24 12.06
52 Week High 24.79
52 Week Low 15.67
BSX Important Levels
Resistance 2 21.04
Resistance 1 20.95
Pivot 20.76
Support 1 20.67
Support 2 20.58
NYSE USA Most Active Stocks
BAC 22.16 1.47%
BAC 22.16 1.47%
BAC 22.16 1.47%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
AMD 9.45 8.87%
AMD 9.45 8.87%
AMD 9.45 8.87%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
IPI 1.82 22.15%
IPI 1.82 22.15%
IPI 1.82 22.15%
IL 13.12 16.42%
SAB 7.20 12.50%
SAB 7.20 12.50%
SAB 7.20 12.50%
SAB 7.20 12.50%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Boston Scientific Corporation (NYSE: BSX)

BSX Technical Analysis 4
As on 6th Dec 2016 BSX Share Price closed @ 20.81 and we RECOMMEND Sell for LONG-TERM with Stoploss of 21.26 & Strong Sell for SHORT-TERM with Stoploss of 22.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
BSX Target for December
1st Target up-side 21.53
2nd Target up-side 22.28
3rd Target up-side 23.03
1st Target down-side 19.39
2nd Target down-side 18.64
3rd Target down-side 17.89
BSX Other Details
Segment EQ
Market Capital 7591556096.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.bostonscientific.com
BSX Address
BSX
One Boston Scientific Place
Natick, MA 01760
United States
Phone: 508-650-8000
Interactive Technical Analysis Chart Boston Scientific Corporation ( BSX NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Boston Scientific Corporation
BSX Business Profile
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker to treat heart failure; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart comprising radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, the company provides endoscopy products to treat diseases of the digestive and pulmonary systems; stone management products to treat patients with urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products; and devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs. Boston Scientific Corporation was founded in 1979 and is headquartered in Natick, Massachusetts.